RESUMO
A randomized comparison trial of two very low calorie weight reduction diets was carried out for 5 or 8 wk in 17 healthy obese women. One diet provided 1.5 g protein/kg ideal body weight; the other provided 0.8 g protein/kg ideal body weight plus 0.7 g carbohydrate/kg ideal body weight. The diets were isocaloric (500 kcal). Amino acid metabolism was studied by means of tracer infusions of L-[1-13C]leucine and L-[15N]alanine. After 3 wk of adaptation to the diets, nitrogen balance was zero for the 1.5 g protein diet but -2 g N/d for the 0.8 g protein diet. Postabsorptive plasma leucine and alanine flux decreased from base line by an equal extent with both diets by approximately 20 and 40%, respectively. It was concluded that protein intakes at the level of the recommended dietary allowance (0.8 g/kg) are not compatible with nitrogen equilibrium when the energy intake is severely restricted, and that nitrogen balance is improved by increasing the protein intake above that level. Basal rates of whole body nitrogen turnover are relatively well maintained, compared with total fasting, at both protein intakes. However, turnover in the peripheral compartment, as evidenced by alanine flux, may be markedly diminished with either diet.
Assuntos
Dieta Redutora/efeitos adversos , Obesidade/metabolismo , Alanina/sangue , Aminoácidos/metabolismo , Ingestão de Energia , Feminino , Humanos , Leucina/sangue , Nitrogênio/metabolismo , Obesidade/dietoterapiaRESUMO
To improve our understanding of the metabolic role of cytokines in protein wasting, we estimated the rates of protein synthesis and degradation in muscle and liver tissues in intact rats treated with several doses of recombinant IL 1 and/or tumor necrosis factor (TNF)/cachectin. Protein breakdown in muscle and liver were derived in vivo from the relationship between [14C]leucine distribution and tissue dilution in reference to circulating leucine. Synthesis was derived from the relationship between [14C]leucine appearance in the protein-bound and free-tissue leucine pools. To specifically relate changes in leucine tracer metabolism to protein dynamics, we separately measured the effect of these cytokines on blood flow to different tissues. The increase in dilution of the tissue-free [14C]leucine by TNF and TNF/IL 1 mixture, but not by IL 1 alone, could not be explained by a hemodynamic effect of these cytokines. Rather, this finding indicated that muscle proteolysis is enhanced by TNF and synergistically augmented by the addition of IL 1. Compatible with these data was the finding that more prolonged infusions of recombinant TNF/cachectin and the combination with IL 1 increased urinary nitrogen excretion. Changes in [14C]leucine dilution in the liver were less pronounced than those in skeletal muscle and consistent with net anabolic effect of TNF on liver protein. We conclude that rats exposed systemically to sublethal doses of TNF respond with increasing muscle and decreasing liver proteolysis, similar to that observed in inflammation and in cancer.
Assuntos
Interleucina-1/administração & dosagem , Músculos/metabolismo , Fator de Necrose Tumoral alfa/administração & dosagem , Animais , Relação Dose-Resposta a Droga , Sinergismo Farmacológico , Hemodinâmica , Humanos , Infusões Intravenosas , Leucina/farmacocinética , Fígado/irrigação sanguínea , Masculino , Músculos/irrigação sanguínea , Nitrogênio/urina , Biossíntese de Proteínas , Proteínas/metabolismo , Ratos , Ratos EndogâmicosRESUMO
Data obtained in vitro suggest that the ability to mobilize fat decreases with age. We determined lipolytic rates in vivo in normal weight young adult (22-33 yr) and elderly (65-77 yr) subjects using a simultaneous infusion of [1,2-13C2]palmitate and [2H5]glycerol. The subjects were studied after a 12-h fast and again after 60-82 h of fasting. When lipolysis was expressed per unit of adipose tissue the values for the young adults were more than double those for the elderly (P less than 0.05). However, the amount of body fat in the elderly was twice that of the young adults, so that lipolysis per unit of body weight was similar in both groups. These results demonstrate that lipolysis per unit of adipose tissue is lower in elderly subjects. This may be due to their increase in body fat, however, since the total amount of potential energy mobilized from adipose tissue was similar to that of the young adults.
Assuntos
Glicerol/metabolismo , Ácidos Palmíticos/metabolismo , Inanição/metabolismo , Tecido Adiposo/metabolismo , Adulto , Idoso , Envelhecimento , Peso Corporal , Humanos , Cinética , Lipólise , Masculino , Matemática , Ácido Palmítico , Fatores de TempoRESUMO
The rate of protein synthesis in vivo was assessed in tumor tissue, skeletal muscle, liver, and the whole body of rats bearing either the Yoshida sarcoma or Novikoff hepatoma after 18 days of tumor growth and compared to tumor-free controls. Changes in size of the whole animal and tumor (i.e., growth) were measured, and fractional rates of growth, synthesis, and degradation were estimated. Muscle protein synthesis and whole-body growth were significantly reduced in both groups of tumor-bearing rats after 18 days of tumor growth. In addition to reductions in muscle protein synthesis, whole-body protein synthesis was significantly reduced in the Yoshida tumor-bearing group (587 +/- 36 versus 401 +/- 40 mg/h; mean +/- SEM; control versus Yoshida group, respectively, P less than 0.01). Tumor protein synthesis was not statistically different between the Yoshida tumor (76 +/- 21 mg/h) and the Novikoff tumor (50 +/- 8) after 18 days of growth despite the fact that the Yoshida tumors were significantly larger (33.9 +/- 4.2 g versus 11.9 +/- 1.2 g; P less than 0.01). The fractional synthesis rate (Ks) was, in fact, significantly slower in the Yoshida versus the Novikoff tumor (36.8 +/- 7.6 versus 55.1 +/- 4.8%/day). Tumor growth (Kg) followed first order growth rates for both tumor types (r = 0.945, 0.869; Kg = 17.2 +/- 1.6, 15.5 +/- 1.9%/day; Yoshida and Novikoff, respectively). The fractional degradation rate of tumor protein (Kd) was determined as the difference between the two first order rate constants Ks and Kg. The tumor protein degradation rate was significantly reduced in the Yoshida tumors compared to the Novikoff tumors (19.6 +/- 8.2% versus 39.6 +/- 4.2%/day, respectively). The greater size in the Yoshida sarcoma can be attributed to reduction in fractional protein degradation rather than change in synthesis rates, which supports the theory that some tumors can regulate their growth by alteration in tumor protein degradation rates (J. A. Tayek et al., Cancer Res., 46:5649-5654, 1986).
Assuntos
Neoplasias Hepáticas Experimentais/metabolismo , Fígado/metabolismo , Proteínas Musculares/metabolismo , Proteínas/metabolismo , Sarcoma de Yoshida/metabolismo , Animais , Peso Corporal , Neoplasias Hepáticas Experimentais/patologia , Masculino , Ratos , Ratos Endogâmicos , Sarcoma de Yoshida/patologiaRESUMO
We have studied the ability of branched chain amino-acid enriched total parenteral nutrition solutions to improve nutritional status without stimulating tumor growth. Protein kinetics, nitrogen balance, tumor kinetics, fractional synthetic rates of individual tissues, and albumin synthesis were compared in male Sprague-Dawley rats (125-145 g) that had either s.c. Yoshida sarcoma (n = 15) or sham implantations (n = 18). Ten days postinjection, rats were randomly assigned to 2 diet groups and given parenteral infusions of 4 days at 170 kcal/kg.body wt.day as dextrose and 2 g N/kg.body wt.day as either 19 or 50% branched chain amino acid-enriched diet. During the last 4 h of feeding, protein kinetic values were studied using a constant infusion of [14C]tyrosine. Plasma tyrosine appearance, synthesis, and breakdown were unchanged by branched chain amino acid infusion. Percentage of tyrosine flux oxidized and tyrosine oxidation decreased (P less than 0.05) and net tyrosine balance improved (P less than 0.05) in rats receiving the branched chain amino acid-enriched diet. Greater nitrogen balance and lower tumor growth rates were also found in branched chain amino acid-infused rats although not statistically significant. Tumor intracellular specific activity was significantly higher in tumor animals receiving crystalline infusions, suggesting greater tumor protein breakdown with branched chain amino acid-enriched infusion. Fractional synthetic rates of liver, muscle, and tumor were unchanged. Hence, branched chain amino acid-enriched total parenteral nutrition increases amino acid utilization for net protein synthesis principally by reducing oxidation without stimulating tumor growth.
Assuntos
Aminoácidos de Cadeia Ramificada/administração & dosagem , Aminoácidos/metabolismo , Nutrição Parenteral Total , Sarcoma de Yoshida/metabolismo , Animais , Gluconeogênese , Masculino , Proteínas/metabolismo , Ratos , Ratos Endogâmicos , Sarcoma de Yoshida/patologiaRESUMO
The present study was designed to determine whether alterations in host metabolism associated with progressive tumor growth were a result of the anorexia frequently observed with cancer or could be attributed to other direct tumor effects. Rates of tyrosine flux, oxidation, and incorporation into protein, as well as fractional protein-synthetic rates in nonsecretory liver, muscle, and tumor, were determined in overnight-fasted rats, 5 to 6 (Stage I), 10 to 11 (Stage II), and 15 to 16 (Stage III) days following s.c. implantation of RNC-254 fibrosarcoma. Tumor-bearing rats were allowed to consume a purified diet containing 20% protein ad libitum, and results were compared to non-tumor-bearing rats pair fed quantities of food equivalent to tumor-bearing animals or allowed to consume the diet ad libitum. Results demonstrate that during later stages of tumor growth (Stage III) calorie intake and nontumor body weight gain were reduced in tumor-bearing rats (p less than 0.05). Fifteen and 16 days following implantation, there were significant changes in amino acid kinetics that were not observed after earlier periods of tumor growth and that could not be explained by any reduction in dietary intake. Rates of tyrosine appearance in the plasma and subsequent incorporation into whole-body protein were increased 33 and 34%, respectively (p less than 0.05), when compared to non-tumor-bearing rats fed equivalent quantities of food. Whole-body tyrosine oxidation rates were unchanged. Skeletal protein synthesis, as reflected by gastrocnemius or rectus abdominus muscle, was reduced from 10.5 and 10.1%/day to 7.4 and 6.0%/day, respectively (p less than 0.05), in tumor-bearing compared to pair-fed animals. The findings suggest that significant alterations in protein metabolism occur in advanced stages of experimental neoplastic disease which cannot be explained by reductions in dietary intake and are aimed at providing adequate quantities of endogenous amino acids for net tumor growth.
Assuntos
Músculos/metabolismo , Neoplasias/metabolismo , Proteínas/metabolismo , Tirosina/metabolismo , Animais , Peso Corporal , Caquexia/etiologia , Proteínas Alimentares , Ingestão de Energia , Feminino , Fígado/metabolismo , Estadiamento de Neoplasias , Neoplasias/complicações , Neoplasias/patologia , Biossíntese de Proteínas , Ratos , Ratos Endogâmicos , Fatores de TempoRESUMO
The in vivo rates of protein synthesis were assessed in tumor tissue, skeletal muscle, and whole body of rats bearing the Walker 256 carcinosarcoma. Estimates of protein synthesis in the nontumorous tissues were compared to tumor-free controls. Changes in size of the whole animal and tumor (i.e., growth) were measured, and fractional rates of growth, synthesis, and breakdown were estimated. Muscle protein synthesis and whole-body growth were significantly reduced in rats bearing larger tumors, and both were negatively correlated with tumor size (r = -0.723 and -0.825, respectively; P less than 0.01). Furthermore, whole-body and muscle protein synthesis were positively correlated with body growth (r = 0.380 and 0.563, respectively; P less than 0.05). Tumor growth followed first-order kinetics between days 7 and 13 following implantation, with a mean rate constant of 34.3%/day for the larger tumors and 27.7%/day for the small tumors. The difference in tumor growth became statistically significant over the final 3 days of tumor volume measurements. Fractional protein synthesis was significantly lower in the larger compared to the smaller tumors (48.6 versus 84.8%/day; P less than 0.05) as measured on day 14. This finding indicates a lower protein breakdown rate for the larger tumors (14.3 versus 59.0%/day; P less than 0.01) and suggests that the process of protein breakdown could play a significant role in determining tumor size, leading support to the theory of tumors acting as nitrogen traps.
Assuntos
Carcinoma 256 de Walker/metabolismo , Proteínas Musculares/metabolismo , Proteínas/metabolismo , Animais , Carcinoma 256 de Walker/patologia , Fígado/anatomia & histologia , Masculino , Proteínas de Neoplasias/metabolismo , Tamanho do Órgão , RatosRESUMO
A protein-sparing modified fast (PSMF), which is a total fast modified by the intake of 1.2-1.4 gm. protein per kilogram ideal body weight (IBW), fluids ad libitum, and vitamin and mineral supplementation, allows effective control of carbohydrate metabolism and hunger. It reduces serum glucose and insulin concentrations in obese diabetic patients and increases free fatty acid and ketone body concentrations; ketonuria appears within 24-72 hours. When this fast was applied to seven obese adult-onset diabetics who were receiving 30-100 units of insulin per day, insulin could be discontinued after 0-19 days (mean, 6.5). In the three patients who had extensive nitrogen-balance studies, balance could be maintained chronically by 1.3 gm. protein per kilogram IBW, despite the gross caloric inadequacy of the diet. The PSMF was tolerated well in an outpatient setting after the initial insulin-withdrawal phase had occurred in the hospital. Significant improvements in blood pressure, lipid abnormalities, parameters of carbohydrate metabolism, and cardiorespiratory, symptoms were associated with weight loss and/or the PSMF. For diabetics with some endogenous insulin reserve, the PSMF offers significant advantages for weight reduction, including preservation of lean body mass (as reflected in nitrogen balance) and withdrawal of exogenous insulin.
Assuntos
Diabetes Mellitus , Jejum , Insulina/uso terapêutico , Nitrogênio/metabolismo , Obesidade , Peso Corporal , Metabolismo dos Carboidratos , Diabetes Mellitus/metabolismo , Diabetes Mellitus/terapia , Proteínas Alimentares , Ácidos Graxos não Esterificados/sangue , Feminino , Humanos , Fome , Corpos Cetônicos/metabolismo , Masculino , Pessoa de Meia-Idade , Minerais/uso terapêutico , Proteínas/metabolismo , Vitaminas/uso terapêuticoRESUMO
The effect of recombinant human interleukin-2 (IL-2) on tumor cell cycle kinetics was evaluated in rats bearing the Walker-256 carcinosarcoma. Seven days after implantation, tumor-bearing rats were infused intravenously with IL-2 at a dose of 500 mg/kg body weight or 5% dextrose for 6 h. Tumor cell mean DNA synthesis time (TDNA), labeling index, potential doubling time (Tpot), and growth fraction (GF) were determined in vivo by use of bromodeoxyuridine (BrdUrd) pulse labeling and bivariate BrdUrd/DNA analysis using flow cytometry. IL-2 treatment significantly reduced the relative number of S-phase cells by 11.9% and increased the number of cells in the G0/G1 phase by 9.4%. The labeling index was reduced from 41.3 +/- 2.5% to 32.7 +/- 1.2% (P < .01). Estimates of TDNA derived from the change in BrdUrd movement relative to DNA content were not affected by IL-2 treatment. Based on these cytokinetic changes, IL-2 infusion significantly increased tumor Tpot from 15.3 +/- 0.3 h to 21.5 +/- 0.2 h (P < .001) and reduced GF from 1.01 +/- 0.07 to 0.83 +/- 0.01 (P < 0.001). The inhibitory effect of IL-2 infusion on tumor cell growth, which may be either direct or secondarily mediated by other factors, contrasts with other stimulatory effects of this cytokine on lymphoid cell proliferation.
Assuntos
Carcinoma 256 de Walker/patologia , Ciclo Celular/efeitos dos fármacos , Interleucina-2/farmacologia , Animais , Divisão Celular/efeitos dos fármacos , DNA de Neoplasias/biossíntese , DNA de Neoplasias/efeitos dos fármacos , Citometria de Fluxo , Infusões Intravenosas , Interleucina-2/administração & dosagem , Cinética , Matemática , Índice Mitótico/efeitos dos fármacos , Modelos Biológicos , Ratos , Ratos Sprague-DawleyRESUMO
Twelve patients with recent weight loss to less than 85% of standard weight-height ratio and a serum albumin level of at least 3 gm/100 ml were considered to have the adult equivalent to marasmus. Cellular immune function was assessed by delayed hypersensitivity skin testing to Monilia and streptokinase-streptodornase, peripheral lymphocyte count, proportion of T and B cells, whole blood and isolated lymphocyte transformation to phytohemagglutinin, pokeweed mitogen, concanavalin A, Monilia, and streptokinase-streptodornase. Significant impairment of skin test reactivity while in vitro responsiveness remained intact was noted in the marasmic patients. No impairment was found in 12 individuals with recent weight loss who remained at a weight greater than the 85% weight-height ratio. In four marasmic individuals in whom weight loss was arrested by nutritional repletion, skin reactivity returned without substantial change in weight. In this type of marasmus, both depleted nutritional status and weight loss must be present for impairement of skin test responsiveness. These findings confirm relative sparing of more vital functions dependent on protein metabolism in adult marasmus compared to the kwashiorkor-like syndromes of hypoalbuminemic malnutrition seen in adults.
Assuntos
Imunidade Celular , Desnutrição Proteico-Calórica/imunologia , Adulto , Fatores Etários , Idoso , Linfócitos B/imunologia , Estatura , Peso Corporal , Criança , Feminino , Humanos , Hipersensibilidade Tardia/diagnóstico , Ativação Linfocitária , Masculino , Pessoa de Meia-Idade , Albumina Sérica/análise , Testes Cutâneos , Linfócitos T/imunologiaRESUMO
Cardiac arrhythmias have been implicated in the deaths of 17 morbidly obese individuals subsisting on a collagen hydrolysate preparation ("liquid protein") during a modified fasting regimen for weight loss. Serious cardiac arrhythmias have been noted in three of six subjects studied prospectively within 28 days of starting a similar regimen, which used an inadequate protein source and was nearly devoid of all essential minerals. A comparative study of three 28-day weight loss diets of varying carbohydrate, protein, and energy content (450 to 820 kcal/day) but employing protein of good quality and adequate in micronutrients did not disclose substantial diet-related arrhythmias in five subjects on each of the three diets. The incidence of arrhythmia seen with liquid protein diets is not likely to be related to the absolute energy or carbohydrate content of the modified fasting regimen itself.
Assuntos
Arritmias Cardíacas/etiologia , Dieta Redutora/efeitos adversos , Carboidratos da Dieta/administração & dosagem , Adulto , Análise de Variância , Análise Química do Sangue , Feminino , Humanos , Cetose/etiologiaRESUMO
Three new techniques have been developed for the treatment of obesity--behavior modification, semistarvation ketogenic regimens, and surgical therapy. Behavior modification appears to be effective for weight maintenance after weight loss through balanced deficit dieting for patients at less than 130 per cent of desirable body weight and semistarvation ketogenic regimens for patients from 130 to 200 per cent of desirable body weight. When indicated, surgical therapy is more efficacious for patients who are in excess of 200 per cent desirable body weight. All three approaches should be considered experimental until a larger experience is acquired and preliminary results are confirmed.
Assuntos
Diabetes Mellitus/terapia , Dieta para Diabéticos , Obesidade , Adolescente , Adulto , Terapia Comportamental , Diabetes Mellitus/psicologia , Diabetes Mellitus/cirurgia , Feminino , Humanos , Íleo/cirurgia , Jejuno/cirurgia , Corpos Cetônicos , Pessoa de Meia-Idade , InaniçãoRESUMO
The bacterial lipopolysaccharide endotoxin induces a catabolic response characterized by resistance to multiple anabolic hormones. The objective of this study was to determine the effects of endotoxin on the GH signaling pathway in rat liver in vivo. After the iv injection of Escherichia coli endotoxin (1 mg/kg), there was a progressive decrease in liver STAT5 (signal transducer and activator of transcription-5) tyrosine phosphorylation in response to GH (40% decrease 6 h after endotoxin), which occurred in the absence of a change in abundance of the STAT5 protein. Endotoxin resulted in a rapid 40-fold increase in liver Janus family kinase-2 (JAK2) messenger RNA, followed by a 2-fold increase in JAK2 protein abundance. This was associated with a 50% decrease in phosphorylated/total JAK2 after GH stimulation. GH receptor abundance was unchanged, suggesting a postreceptor site of endotoxin-induced GH resistance. Rat complementary DNAs for three members of the suppressor of cytokine signaling gene family were cloned [cytokine-inducible sequence (CIS), suppressor of cytokine signaling-2 (SOCS-2), and SOCS-3] and, using these probes, messenger RNAs for SOCS-3 and CIS were shown to be increased 10- and 4-fold above control values, respectively, 2 h after endotoxin infusion. The finding of endotoxin inhibition of in vivo STAT5 tyrosine phosphorylation in response to a supramaximal dose of GH in the absence of a change in GH receptor abundance or total GH-stimulated JAK2 tyrosine phosphorylation provides the first demonstration of acquired postreceptor GH resistance. We hypothesize that this may occur through a specificity-spillover mechanism involving the induction of SOCS genes by cytokines released in response to endotoxin and subsequent SOCS inhibition of GH signaling.
Assuntos
Endotoxinas/farmacologia , Fígado/metabolismo , Proteínas do Leite , Proteínas Proto-Oncogênicas , Receptores da Somatotropina/fisiologia , Proteínas Repressoras , Transdução de Sinais , Fatores de Transcrição , Animais , Proteínas de Ligação a DNA/metabolismo , Escherichia coli , Expressão Gênica , Hormônio do Crescimento Humano/farmacologia , Janus Quinase 2 , Masculino , Fosforilação , Fosfotirosina/metabolismo , Proteínas Tirosina Quinases/genética , Proteínas/genética , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-Dawley , Fator de Transcrição STAT5 , Proteína 3 Supressora da Sinalização de Citocinas , Proteínas Supressoras da Sinalização de Citocina , Transativadores/metabolismoRESUMO
GH has been shown to stimulate tyrosine phosphorylation of JAK2, several STAT proteins, insulin receptor substrate-1 (IRS-1), and SHC proteins in cultured cells. The goal of this study was to determine GH effects on protein tyrosine phosphorylation in liver and skeletal muscle of normal rats in vivo. Nonfasted male Sprague-Dawley rats (225-250 g) were injected with GH iv, and tissues were obtained after 5, 15, 30, or 60 min. At a maximally effective GH dose (1.5 mg/kg body weight), phosphotyrosine antibody immunoblots demonstrated marked stimulation of the tyrosine phosphorylation of JAK2 (maximal at 5 min) and a 95,000 Mr protein (maximal at 15 min) in both liver and skeletal muscle. The 95,000 Mr protein was recognized and immunodepleted by STAT5 antibody, but not by other STAT protein antibodies. Although basal tyrosine phosphorylation of IRS-1 and SHC was evident, GH did not stimulate tyrosine phosphorylation of either of these proteins in liver or skeletal muscle. In conclusion, GH stimulates the tyrosine phosphorylation of JAK2 and STAT5, but not IRS-1, SHC, or other STAT proteins in liver and skeletal muscle of normal rats. These results differ from findings in cultured cells and support the concept that selectivity for tyrosine kinase substrates is an important determinant of postreceptor signaling specificity in vivo.
Assuntos
Proteínas Adaptadoras de Transdução de Sinal , Proteínas Adaptadoras de Transporte Vesicular , Proteínas de Ligação a DNA/metabolismo , Hormônio do Crescimento/farmacologia , Fígado/metabolismo , Proteínas do Leite , Músculo Esquelético/metabolismo , Fosfoproteínas/metabolismo , Fosfotirosina/metabolismo , Proteínas Tirosina Quinases/metabolismo , Proteínas/metabolismo , Proteínas Proto-Oncogênicas , Transativadores/metabolismo , Animais , Proteínas de Ligação a DNA/isolamento & purificação , Fator de Crescimento Epidérmico/farmacologia , Humanos , Proteínas Substratos do Receptor de Insulina , Janus Quinase 2 , Cinética , Fígado/efeitos dos fármacos , Masculino , Peso Molecular , Músculo Esquelético/efeitos dos fármacos , Fosfoproteínas/isolamento & purificação , Fosforilação , Proteínas Tirosina Quinases/isolamento & purificação , Proteínas/isolamento & purificação , Ratos , Ratos Sprague-Dawley , Proteínas Recombinantes/farmacologia , Fator de Transcrição STAT5 , Proteínas Adaptadoras da Sinalização Shc , Transdução de Sinais , Proteína 1 de Transformação que Contém Domínio 2 de Homologia de Src , Fatores de Tempo , Transativadores/isolamento & purificaçãoRESUMO
Estimated rates of total body protein synthesis breakdown, and amino nitrogen flux were determined in five obese females using [15N]glycine. The subjects were fed a baseline diet of 1.5 g protein/kg ideal BW and 1602 +/- 146 Cal total for at least 3 days, followed by 3 weeks where the sole caloric intake was a mixed diet of 0.8 g meat protein and 0.7 g carbohydrate/kg ideal BW and approximately 437 +/- 44 Cal. Amino nitrogen flux, total body protein synthesis, and breakdown values were 289 +/- 56, 198 +/- 37, and 202 +/- 47 g protein/day (187 +/- 24, 129 +/- 19, and 131 +/- 21 g protein/g creatinine) initially and fell significantly (P less than 0.01) to 192 +/- 30 (P less than 0.005), 138 +/- 27 (P less than 0.01), and 146 +/- 25 (P less than 0.01) g protein/day [125 +/- 13 (P less than 0.001), 90 +/- 14 (P less than 0.005), and 95 +/- 11 (P less than 0.005) g protein/g creatinine] by the final 60 h of the third week. Nitrogen balance remained significantly negative (P less than 0.01) during each week of the mixed diet and overall (--3.3 +/- 0.9 g N/day; P less than 0.01). Thus, total body protein synthesis and the net balance between synthesis and catabolism are not maintained with this diet.
Assuntos
Carboidratos da Dieta/administração & dosagem , Proteínas Alimentares/administração & dosagem , Jejum , Nitrogênio/metabolismo , Adulto , Peso Corporal , Dieta Redutora , Feminino , Humanos , Obesidade/metabolismo , Proteínas/metabolismoRESUMO
We measured the degree of association between obesity, blood pressure, insulin resistance, and insulin secretion in 72 male and female obese hypertensive, obese nonhypertensive, and normal weight control subjects. Baseline weight, body mass index, percent body fat, waist/hip ratio, and systolic and diastolic blood pressures were obtained. Insulin sensitivity was assessed according to Bergman's minimal model. Twelve-hour urinary c-peptide was measured after a standard liquid meal. Insulin action was inversely associated with blood pressure status, obesity status, and age. Meal-stimulated c-peptide excretion significantly correlated with systolic blood pressure and percent fat but not with body mass index or age. Multivariate regression analysis indicated that, of the measures of body composition, percent fat and waist/hip ratio had the strongest correlation with insulin action either alone or in combination with c-peptide excretion. Obese hypertensive patients had an index of insulin action (10(-4).min-1/[microunits/ml]) of 1.34 +/- 0.19, which was significantly (p less than 0.003) lower than in the obese nonhypertensive patients (index, 2.26 +/- 0.10) or the nonobese subjects (index, 5.41 +/- 0.26, p less than 0.001). Meal-stimulated c-peptide excretion (nmol/kg lean body mass) was increased only in the obese hypertensive group (0.32 +/- 0.01) and was significantly higher (p less than 0.001) than in the obese nonhypertensive (0.16 +/- 0.01) or the nonobese subjects (0.14 +/- 0.01). These results support the hypothesis that abnormalities in blood pressure regulation, insulin-stimulated glucose uptake, and insulin secretion coexist.
Assuntos
Pressão Sanguínea/fisiologia , Hipertensão/etiologia , Resistência à Insulina/fisiologia , Insulina/metabolismo , Insulina/fisiologia , Obesidade/complicações , Adulto , Glicemia/metabolismo , Índice de Massa Corporal , Peptídeo C/urina , Análise por Conglomerados , Diástole , Ingestão de Alimentos , Feminino , Humanos , Hipertensão/fisiopatologia , Hipertensão/urina , Secreção de Insulina , Masculino , Pessoa de Meia-Idade , Obesidade/fisiopatologia , Obesidade/urina , SístoleRESUMO
The reproductive hormone response to severe caloric restriction (600 Cal day-1) was studied in six men 33-67% over ideal body weight who completed a 32-day protocol consisting of three periods in the following order: control (4 days), maintenance protein and energy; diet A (14 days), 50 g lean beef protein plus 50 g casein; and diet B (14 days), 50 g lean beef protein plus 50 g carbohydrate. Weight loss (8.7-12.5 kg) was associated with a decrease in mean blood glucose [4.52 +/- 0.60 (+/- SEM), 3.49 +/- 0.29, and 3.80 +/- 0.30 mM] and an increase in beta-hydroxybutyrate (less than 0.10, 2.09 +/- 0.44, and 1.06 +/- 0.34 mM), as determined on the final morning of each period. On the same days, mean serum FSH and LH responses to LHRH infusion of 0.2 micrograms min-1 for 4 h (expressed as milliinternational units per ml area under the concentration-time curve) were: FSH, 1558 +/- 359, 1336 +/- 545, and 1337 +/- 321 (P = NS); and LH, 1730 +/- 545, 1612 +/- 481, and 1782 +/- 556 (P = NS), respectively. Basal serum FSH, LH, free testosterone (T), and total T changed, while 24-h urinary LH and FSH excretion increased on diet A only. Unlike 10 days of total fasting, during which the same amount of weight was lost, basal serum FSH and LHRH-stimulated serum FSH responses were both significantly diminished by 25%, and serum T was diminished by 19% (1), these same parameters were little changed by either low energy diet. The increased urinary excretion of FSH and LH during diet A suggests that greater ketosis increases renal gonadotropin clearance.
Assuntos
Jejum , Hormônio Foliculoestimulante/sangue , Hormônio Luteinizante/sangue , Testosterona/sangue , Adulto , Dieta Redutora , Proteínas Alimentares/farmacologia , Hormônio Foliculoestimulante/urina , Hormônio Liberador de Gonadotropina , Humanos , Hormônio Luteinizante/urina , Masculino , Pessoa de Meia-Idade , Obesidade/dietoterapia , Obesidade/metabolismoRESUMO
A substantial portion of hospitalized patients suffer from protein-calorie malnutrition acquired as a result of their illness, their semistarvation dietary regimens, or the combination of both insults together. When energy needs are not met by the diet, the deficient calories must come from body stores, muscle, or visceral protein and fat. The status of these stores can be assessed clinically by easily performed measurements. In adult kwashiorkor-like syndromes, the insulin response to the combined stimulus of catabolic stress and carbohydrate feedings reduces the mobilization of fat and protein stores. In adult marasmus there is hypoaminoacidemia and loss of skeletal muscle. Both forms of malnutrition have a profound impact on immune function. Nutritional support should be given preeminent consideration as an additional necessary form of these patients.
Assuntos
Doença/metabolismo , Infecções/etiologia , Desnutrição Proteico-Calórica , Adulto , Dietoterapia/efeitos adversos , Hospitalização , Humanos , Infecções/complicações , Kwashiorkor , Metabolismo dos Lipídeos , Desnutrição Proteico-Calórica/complicações , Desnutrição Proteico-Calórica/etiologia , Desnutrição Proteico-Calórica/imunologia , Proteínas/metabolismoRESUMO
To assess the catabolic effects of mild infectious illness on protein metabolism, the metabolic responses to incidental infections were studied in four obese patients undergoing a modified fast consisting of a low calorie diet essentially free of carbohydrate but meeting protein needs. In six infectious episodes investigated, there was no change in urinary nitrogen excretion. Nitrogen balance was positive when protein intake was maintained at 0.8-1 g/kg body weight in four of five episodes, despite intakes of less than 700 kcal. These preliminary data from patients experiencing infections under these conditions suggest possibilities for significant reduction in catabolic losses in other stress situations.
Assuntos
Infecções/metabolismo , Nitrogênio/metabolismo , Obesidade/metabolismo , Adulto , Dieta Redutora , Proteínas Alimentares/administração & dosagem , Jejum , Feminino , Febre , Humanos , Masculino , Proteínas/metabolismoRESUMO
The ability of human endogenous pyrogen (EP) harvested from malnourished patients (marasmic or kwashiorkor-like) to induce fever and a simultaneous hypoferremia in rabbits is described. Human peripheral blood leukocytes were obtained from malnourished adult patients before total parenteral nutrition support, and after 1 and 7 days on this therapeutic regime; the leukocytes were stimulated to produce EP in vitro and EP was injected into each rabbit. EP obtained from the leukocytes of patients with predominant protein deprivation syndromes (kwashiorkor) before nutritional support produced an attenuated fever (0.23 degrees C over 4 h) and a relatively unchanged plasma iron concentration (delta Fe = -15 microgram/100 ml over 4 h) in the rabbits. When EP was harvested from these same patients after 7 days of nutritional support therapy and was injected into rabbits, normal 4 h fevers (1.10 degrees C) and reduction in plasma iron levels (delta Fe = -97 micrograms/100 ml) occurred in the rabbits. Human EP obtained from patients with marasmus (predominant calorie deprivation syndromes) produced relatively normal fevers and changes in plasma iron levels in the rabbits, regardless of whether the samples were taken pre-total parenteral nutrition or after 1 and 7 days of total parenteral nutrition. These observations suggest that the synthesis of endogenous pyrogen by human peripheral leukocytes is sensitive to the availability of key substrates and that nutritional support therapy restores the capacity of these cells to produce EP in vitro.